Friday, February 8, 2013

• Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenicsat TheStreet (Fri, Feb 8)

Wednesday, February 6, 2013

• 3 Biopharma Catalyst Trades To Consider For Todayat Seeking Alpha (Wed, Feb 6)

Tuesday, February 5, 2013

• 3 Stocks Under $5 Making Big Movesat TheStreet (Tue, Feb 5)

Monday, February 4, 2013

• ImmunoCellular Therapeutics to Present at BIO CEO & Investor Conference on February 11thBusiness Wire (Mon, Feb 4)

Friday, February 1, 2013

• Investors Discounting Positive Data Readout On Brain Cancer Studiesat Seeking Alpha (Fri, Feb 1)

Thursday, January 31, 2013

• 2 Small-Cap Biotechs With Zero Debt And Potentially Beneficial Long-Term Catalystsat Seeking Alpha (Thu, Jan 31)

Wednesday, January 30, 2013

• IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other EventsEDGAR Online (Wed, Jan 30)

Tuesday, January 29, 2013

• ImmunoCellular Therapeutics’ Investigational New Drug (IND) Application for ICT-140 Allowed by the FDABusiness Wire (Tue, Jan 29)

Thursday, January 17, 2013

• Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for ReplacementsMarketwired (Thu, Jan 17)

Monday, January 7, 2013

• ImmunoCellular Therapeutics Provides Update on Corporate MilestonesBusiness Wire (Mon, Jan 7)

Wednesday, January 2, 2013

• IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Jan 2)
• The Twitterverse's Biotech Stock Picks for 2013at TheStreet (Wed, Jan 2)
• ImmunoCellular Therapeutics Appoints Gary S. Titus to its Board of DirectorsBusiness Wire (Wed, Jan 2)

Wednesday, December 19, 2012

• 7 Companies Fighting To Cure Cancerat Seeking Alpha (Wed, Dec 19)

Thursday, December 6, 2012

• IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Thu, Dec 6)

Tuesday, December 4, 2012

• ImmunoCellular Shares Near Lows Offer A Speculative Oncology Playat Seeking Alpha (Tue, Dec 4)

Monday, December 3, 2012

• ImmunoCellular Therapeutics names Gengos as CEOAP (Mon, Dec 3)
• ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive OfficerBusiness Wire (Mon, Dec 3)

Wednesday, November 21, 2012

• ImmunoCellular Therapeutics: An Opportunity For Great Upside Potentialat Seeking Alpha (Wed, Nov 21)

Monday, November 19, 2012

• Biotech Industry Experiencing More FDA New Drug Approvals in 2012Marketwired (Mon, Nov 19)

Monday, November 12, 2012

• ImmunoCellular Therapeutics Reports Third Quarter 2012 Financial ResultsBusiness Wire (Mon, Nov 12)

Friday, November 9, 2012

• IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Fri, Nov 9)

Monday, November 5, 2012

• ImmunoCellular Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference on November 14thBusiness Wire (Mon, Nov 5)

Thursday, November 1, 2012

• FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating DiseasesMarketwired (Thu, Nov 1)

Friday, October 19, 2012

• Healthcare Business Update: Pfizer Gets New Results, Novovax Studies Meet Goalsat Wall St. Cheat Sheet (Fri, Oct 19)

Add IMUC News to My Yahoo!